Skip to content

Insider · CIK 0001754555

Jason K Garland

cfoofficer

Files at RGEN (REPLIGEN CORP). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 25, 2026RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-421$189.68$80k18,40814 d ago
Mar 5, 2026RGEN
REPLIGEN CORP
AGrant or award
Common Stock
+7,751$0.00$020,092Mar 23, 2026
Mar 5, 2026RGEN
REPLIGEN CORP
AGrant or award
Stock Option (Right to Buy)derivative
+8,315$0.00$08,315Mar 23, 2026
Feb 27, 2026RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-327$128.73$42k13,056Mar 3, 2026
Mar 2, 2026RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-715$124.97$89k12,341Mar 3, 2026
Sep 25, 2025RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-412$121.68$50k13,383Sep 26, 2025
Mar 3, 2025RGEN
REPLIGEN CORP
AGrant or award
Common Stock
+6,435$0.00$013,795Mar 4, 2025
Mar 3, 2025RGEN
REPLIGEN CORP
AGrant or award
Stock Option (Right to Buy)derivative
+6,056$0.00$06,056Mar 4, 2025
Feb 27, 2025RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-316$156.54$49k7,360Feb 28, 2025
Nov 20, 2024RGEN
REPLIGEN CORP
FTax withholding
Common Stock
-367$123.41$45k7,676Nov 21, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jason K Garland: insider trades and track record | InsiderTell